China Demands Meta Cancel Manus Acquisition, Intensifies Pressure on Global AI Deals

China has demanded that Meta reconsider an already-closed deal to acquire AI startup Manus for $2 billion, marking what appears to be a new level of Beijing's intervention in global technology transactions. If Chinese authorities previously relied mainly on internal restrictions, antitrust investigations, and control over the domestic market, the conversation now centers on attempts to reverse an acquisition that was agreed and completed outside Chinese jurisdiction. For the international market, this sends a signal: in an era of competition for AI assets, even a formally completed deal may not be considered final.

Beijing has spent years trying to influence corporate decisions far beyond its borders, especially when sensitive technologies, data, chips, infrastructure, or strategic developer teams are at stake. But the Manus story stands out even against this backdrop. In essence, China is demonstrating that it is willing to use not only control over its own companies and supply chains, but also political leverage to reshape competition in the global race for artificial intelligence.

For Meta, this is particularly painful: the company is already playing catch-up with leaders in generative AI, and the Manus acquisition, judging by the deal's scale, was seen as a way to quickly strengthen its team, models, and research capabilities. The $2 billion figure underscores that this is not an early experiment but an important strategic asset. In the current AI development cycle, large platforms are buying not just products but access to talent, computational advances, data, patents, and the speed of launching new services.

Therefore, an attempt to reverse such a deal is a blow not only to the specific buyer but to the logic of M&A transactions in the technology market itself. The higher the uncertainty after deal closure, the more expensive cross-border acquisitions become, the longer legal reviews take, and the steeper the discount applied to any assets with politically sensitive ties to China. For other American and European technology companies, the situation is equally telling.

If this precedent takes hold, buyers will begin to account in advance not only for US, EU, and target jurisdiction regulators, but also for Beijing's position, even when the deal formally occurs outside its territory. This changes the risk map itself. Boards of directors will need to analyze more deeply the origins of key engineers, startups' dependence on Chinese supply chains, the presence of research centers in China, and any legal points through which Chinese authorities could delay integration.

In the AI sector, where speed is critical, such a delay could cost a lost year and strategic setback. For startups and their investors, this too is an unwelcome turn. Usually, after a deal is announced and closed, attention shifts to team integration, retention of key employees, and launch of a joint product strategy.

If there remains a risk of external political intervention, founders and funds gain a new discount: money may be agreed, documents signed, and yet the outcome remains uncertain. This is especially important for AI companies built around small research collectives. A few months of uncertainty can dismantle a team, disrupt hiring, and deny the buyer the very value it paid a premium for.

What this means. The Meta and Manus story shows that the struggle for control over artificial intelligence looks less and less like ordinary company competition and increasingly like geopolitical rivalry between states. The market receives a harsh lesson: buying an AI startup now depends not only on price, synergy, and shareholder approval, but also on which states consider the technology, talent, or infrastructure part of their strategic sphere of influence. If this pattern of behavior becomes the norm, international AI deals will close more slowly, cost more, and more often fall apart even after signing.